Effect of Depressin Screening and Care Program at Community Health Center

The recruitment status of this study is unknown because the information has not been verified recently.

Verified June 2012 by National Clinical Research Coordination Center, Seoul, Korea.
Recruitment status was Recruiting

Sponsor:

Information provided by:

National Clinical Research Coordination Center, Seoul, Korea

ClinicalTrials.gov Identifier:

NCT01626703

First received: June 20, 2012

Last updated: June 22, 2012

Last verified: June 2012

History of Changes

Purpose

Depression affect between 5% and 10% of older adults seen in the primary care setting.Late-life depression is often chronic or recurrent and is associated with substantial suffering, functional impairment, and diminished health-related quality of life.Depressed, older primary care patients are frequent users of general medical services and may have poor adherence to medical treatments.They are also at increased risk of death from suicide and medical illnesses. The aim of this study is to examine whether depression screening and health care practitioner feedback are increased depression treatment rate.

Depression screening is provided 60 or more who visited community health care center with a 15-item Geriatric Depression Scale.GDS scores of 10 or more were classified depression positive. Intervention group participants received twice remind calls from primary care nurse.

Condition	Intervention
Depression Screening Elderly	Other: Reminding call


Study Type:	Interventional
Study Design:	Endpoint Classification: Efficacy Study Intervention Model: Single Group Assignment Masking: Double Blind (Subject, Outcomes Assessor) Primary Purpose: Screening

Further study details as provided by National Clinical Research Coordination Center, Seoul, Korea:

Primary Outcome Measures:

Reuptake rate [ Time Frame: 12 weeks ] [ Designated as safety issue: No ]

Secondary Outcome Measures:

reduced depressive symptoms [ Time Frame: 12 weeks ] [ Designated as safety issue: No ]
Geriatric Depression Scale Short Form (SGDS)
changed perceived heath status [ Time Frame: 12 weeks ] [ Designated as safety issue: No ]
Visual Analogue Scale (VAS)


Estimated Enrollment:	86
Study Start Date:	June 2012
Estimated Study Completion Date:	March 2013
Estimated Primary Completion Date:	December 2012 (Final data collection date for primary outcome measure)

Eligibility


Ages Eligible for Study:	60 Years and older
Genders Eligible for Study:	Both

Criteria

Inclusion Criteria:

60 or more
10 or more in GDS scor

Exclusion Criteria:

severe cognitive problem

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01626703

Contacts


Contact: Hyeon-Woo Yim, MD, Ph.D	+82-2-2258-7860	y1693@catholic.ac.kr
Contact: Hyunsuk Sue Jeong, MA	+82-2-2258-7372	suejeong@catholic.ac.kr

Locations


Korea, Republic of
Chungju community health care center	Recruiting
Chungju, Choongbuk, Korea, Republic of, 123456
Contact: Moon-Soon Song, BA +82-43-850-3510 sms5609@korea.kr

Sponsors and Collaborators

National Clinical Research Coordination Center, Seoul, Korea

More Information

No publications provided


ClinicalTrials.gov Identifier:	NCT01626703 History of Changes
Other Study ID Numbers:	A102065_2012_2
Study First Received:	June 20, 2012
Last Updated:	June 22, 2012
Health Authority:	Korea: Ministry of Health and Welfare

ClinicalTrials.gov processed this record on March 01, 2015

To Top